Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study. J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Apr. 18];7(6):s293. Available from: https://skin.dermsquared.com/skin/article/view/2414